CLAYTON FOUNDATION FOR RESEARCH

As filed

Subsection

03

NTEE code

H990

Classification

1280

Street

1 RIVERWAY STE 1500

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Other organizations at this address

1 other organization in the IRS Business Master File lists the same street address. matched by us

This address is a suite or unit (STE 1500). Organizations that share one are often clients of the same office-services firm, accountant or registered agent rather than related to each other.

We match the street line and ZIP code as the IRS gives them, ignoring case and outer spaces and nothing else, so "AVE" and "AVENUE" count as different streets and this list can miss some. A shared address can mean related organizations or a shared office, but it can also be a registered agent, a mail drop or a service provider holding mail for unrelated clients. It is not, by itself, evidence that two organizations are connected.

• CLAYTON FOUNDATION COMPANY

  EIN 74-6035675

Mission and programs · 2024

• Withheld by Nonprofiteer: this text may name a private individual.

  Expenses $1,030,206

• A research project at Baylor College of Medicine in gene and protein therapy focuses on inappropriate cell division and cell death within the human body. Much of the work is devoted to intraocular angiogenesis, with particular attention to: (1) the signals that control this process, (2) the development of animal models of human ocular disease, and (3) development of potential therapies. New targets have been identified and potential therapeutic agents are being developed and tested for the treatment of wet AMD, Diabetic Retinopathy, and Retinopathy of Prematurity.

  Expenses $964,510

• The conduct of a longstanding research program at the University of Texas M. D. Anderson Cancer Center(which program moved to Texas A&M Institute of Biosciences and and Technology during the year) , the purpose of which is to design and develop novel targeted therapeutic agents that target a powerful human toxin to specifically destroy cancer cells for the treatment of numerous cancer targets and other disease indications. A number of collaborations have been undertaken with researchers at various institutions (e.g., University of California San Diego). Patent applications have been filed by Research Development Foundation (RDF), a tax exempt supporting organization of the Foundation (see schedule R, Part III), on more than twenty discoveries, and a number of patents have been issued. Licensing efforts have been ongoing and have resulted in several licenses.

  Expenses $910,134

• Vaccines, Diagnostics and Therapeutics for the Ehrlichioses at The Univerity of Texas Medical Branch at Galveston

  Expenses $825,546

• Development of Biorepository and Novel Therapeutic Strategies for Hepatocellular Carcinoma at the University of Texas Health Science Center at San Antonio

  Expenses $807,116

• Early Detection and Treatment of Glaucoma Baylor College of Medicine Houston

  Expenses $674,935

• Identification of Host-based Antiviral Targets at the University of Texas Southwestern Medical Center Dallas

  Expenses $637,144

• The Use of Light for Cardiological, Surgical, and Related Purposes at the University of Texas Health Science Center at San Antonio

  Expenses $622,259

• Antibody Discovery and Optimization Using the Eclonal Technology at The University of Texas at Austin

  Expenses $589,586

• Electroceutical Sciences and Medicine at Dell Medical School at the University of Texas

  Expenses $495,150

As filed on the 2024 return. The first 10 program lines listed; the rest are in the source return and the API. The filer continues this part on Schedule O, which is not shown here. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.

Officers and directors · 2024

As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

• 2024

  Revenue

  $14,857,333

  Expenses

  $10,938,202

  Contributions

  $2,025,000

  Grants paid

  $51,500

• 2023

  Revenue

  $11,043,790

  Expenses

  $10,750,530

  Contributions

  $8,075,000

  Grants paid

  $150,000

• 2022

  Revenue

  $6,604,622

  Expenses

  $10,006,620

  Contributions

  $3,825,000

  Grants paid

  $150,000

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

• 2021 · 990

  Revenue

  $10,982,705

  Expenses

  $10,317,749

  Assets (EOY)

  $144,911,994

• 2020 · 990

  Revenue

  $10,487,160

  Expenses

  $9,206,656

  Assets (EOY)

  $120,838,913

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all.

Grants made

• The University of Texas MD Anderson Cancer Center

  $100,000

  2023 · Gen Purpose

• Georgetown University

  $15,000

  2022 · Gen Purpose

• National MS Society

  $10,000

  2022 · Gen Purpose

• Georgetown University

  $10,000

  2024 · Gen Purpose

Where these grants went next →

Grants received

• RESEARCH DEVELOPMENT FOUNDATION

  $5,500,000

  2023 · General Support

• FOUNDATION FOR RESEARCH

  $2,575,000

  2023 · Gen Support

• RESEARCH DEVELOPMENT FOUNDATION

  $2,125,000

  2022 · General Support

• FOUNDATION FOR RESEARCH

  $1,775,000

  2024 · Gen Support

• FOUNDATION FOR RESEARCH

  $1,700,000

  2022 · Gen Support

Related organizations

From Schedule R Part II, where a filer lists the tax-exempt organizations it is related to by control. It does not record shared board members or money.

Taxable family

From Schedule R Parts I, III and IV: entities that legally are the filer, and taxable partnerships, corporations and trusts it is related to. These record ownership and control, not shared board members or money.

Other IRS files